PharmEasy is staring at hard times
The online drugs and medical services startup made some costly acquisitions in a bid to pull off an IPO at a high valuation. That plan may be coming unstuck.
July 21, 2022•5 min
0
July 21, 2022•5 min
0
More in Business
Business
B.R. Shetty gets called out in Dubai for lying under oath
A Dubai court’s verdict against the disgraced NMC founder, XPANCEO’s new, expanded laboratory and other headlines from the week.
You may also like
Internet
Peak XV Partners should win the record outcome test with Pine Labs
Finally, this question will be answered. Who has returned the most amount of capital on any venture investment in India in the last two decades?
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Internet
Can Naveen Tahilyani fix Tata Digital’s rot?
The flop show of the super app Tata Neu isn’t the biggest problem for Tata Sons chairman N Chandrasekaran. The new CEO he has now picked has more fundamental issues to fix.